Enterprise AI Analysis
We Need Granular Sharing of De-Identified Data–But Will Patients Engage? Investigating Health System Leaders' and Patients' Perspectives on A Patient-Controlled Data-Sharing Platform
This study investigates how health system leaders and patients perceive granular control over de-identified medical data sharing for research. It reveals a shared appreciation for transparency and autonomy, but also critical tensions and divergent views on implementation and perceived risks.
Executive Impact: Empowering Patients, Advancing Research
Patient-controlled data-sharing platforms offer a transformative approach to medical research, balancing individual autonomy with societal health benefits. Our findings provide key insights for healthcare leaders to design and implement trustworthy, effective systems.
0
Total Participants (Leaders & Patients)
0
Patients Willing to Use Platform
0
Patients Confident in Safeguards
0
Leaders Appreciated Transparency
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Understanding the Study Design
To investigate both health system leaders' and patients' perspectives on granular de-identified data sharing, we employed a two-phase mixed-methods study. This involved developing a high-fidelity prototype as a design probe, followed by semi-structured interviews and a large-scale patient survey.
Enterprise Process Flow: Researching Patient Data Sharing
Developed High-Fidelity Prototype
→
Phase 1: Leader Interviews (16 Participants)
→
Refined Inquiry & Survey Design
→
Phase 2: Patient Survey (523 Participants)
→
Simulated Real-World Interaction
→
Data Analysis & Comparative Insights
Contrasting Views: Leaders vs. Patients
While both health system leaders and patients valued increased autonomy and transparency, their underlying motivations and concerns diverged significantly. Leaders focused on institutional ethics and research quality, whereas patients prioritized privacy, risk mitigation, and personal benefits.
| Feature/Concern | Health System Leaders' Perspective | Patients' Perspective |
|---|---|---|
| Granular Control |
|
|
| Transparency |
|
|
| De-Identified Data Risk |
|
|
| Implementation Challenges |
|
|
Navigating Tensions and Designing for Trust
The study highlights critical tensions between individual control and societal benefit, and between simplicity and informed choice. Addressing these requires flexible, benefit-centered, and literacy-adaptive system designs that balance patient autonomy with robust research infrastructure.
Key Patient Concern Highlight
40% Patients were least willing to share Pregnancy-Related Information (across all organization types), highlighting sensitivity and need for granular control.Addressing Sensitive Data Sharing: A Flexible Granularity Scenario
The platform's flexible granularity feature directly addresses patient hesitation around sensitive data, such as mental health information. Instead of an 'all-or-nothing' approach, patients can specifically opt out of sharing mental health records while still contributing other valuable data.
This design allows individuals to safeguard highly personal information, increasing their overall willingness to participate in research and reducing the risk of skewing datasets due to complete opt-outs. For instance, a patient might share general primary care data with a non-profit for diabetes research, but withhold their psychiatric history, fostering trust and broader participation.
Calculate Your Potential ROI with AI
Estimate the efficiency gains and cost savings your enterprise could achieve by implementing AI solutions tailored to your industry and operational scale.
Estimated Annual Savings
$0
Annual Hours Reclaimed
0
Your AI Implementation Roadmap
A structured approach ensures successful AI adoption, from initial strategy to ongoing optimization and value realization.
Phase 1: Discovery & Assessment
In-depth analysis of current workflows, data infrastructure, and patient/leader requirements. Identify key areas for granular consent implementation and define project scope, privacy policies, and ethical guidelines.
Phase 2: Prototype & Pilot Deployment
Develop and test patient-controlled data sharing prototype with a limited user group. Gather feedback from both patients and health system leaders to refine granularity, transparency, and user experience features.
Phase 3: Full-Scale Integration & Training
Integrate the platform with existing EHR systems and institutional research workflows. Provide comprehensive training for staff and educational resources for patients on how to use the new system effectively.
Phase 4: Monitoring & Continuous Optimization
Monitor platform adoption, patient engagement, and research data contribution rates. Implement iterative improvements based on performance data and evolving patient/leader feedback, ensuring long-term value and trust.
Ready to Transform Your Data Sharing?
Unlock the full potential of patient-controlled data platforms for ethical and efficient medical research. Our experts are ready to guide you.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat